Similar Search Results

International impact of external reference pricing : should national policy-makers care?

Fontrier, Anna-Maria; Gill, Jennifer; Kanavos, Panos - In: The European journal of health economics : HEPAC ; … 20 (2019) 8, pp. 1147-1164

Persistent link: https://www.econbiz.de/10012221319

Variations in external reference pricing implementation : does it matter for public policy?

Gill, Jennifer; Fontrier, Anna-Maria; Kyriopoulos, Dionysis - In: The European journal of health economics : HEPAC ; … 20 (2019) 9, pp. 1375-1397

Persistent link: https://www.econbiz.de/10012221376

Using health technology assessment to assess the value of new medicines : results of a systematic review and expert consultation across eight European countries

Angelis, Aris; Lange, Ansgar; Kanavos, Panos - In: The European journal of health economics : HEPAC ; … 19 (2018) 1, pp. 123-152

Persistent link: https://www.econbiz.de/10011946167

Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States

Kanavos, Panos - In: Health Policy 118 (2014) 2, pp. 229-241

This paper develops a methodological framework to help evaluate the performance of generic pharmaceutical policies post-patent expiry or after loss of exclusivity in non-tendering settings, comprising five indicators (generic availability, time delay to and speed of generic entry, number of...

Persistent link: https://www.econbiz.de/10011116924